Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Lucira Health, Inc. (LHDX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
1.1400-0.0200 (-1.72%)
At close: 04:00PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Short-term KST

Short-term KST

Previous Close1.1600
Open1.1700
Bid1.1600 x 800
Ask1.2900 x 4000
Day's Range1.1200 - 1.2600
52 Week Range1.1200 - 9.6300
Volume33,500
Avg. Volume49,755
Market Cap45.721M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.9900
Earnings DateNov 09, 2022 - Nov 14, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est3.50
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for LHDX

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Lucira Health, Inc.
    Daily – Vickers Top Buyers & Sellers for 07/14/2022The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
    Rating
    Fair Value
    Economic Moat
    2 months agoArgus Research
View more
  • American City Business Journals

    How Covid set up Lucira Health for a possible flu test (and more)

    The company hopes to hear back from the FDA before flu season begins on whether it can market its at-home combined Covid-flu test under an emergency use authorization.

  • GlobeNewswire

    Lucira Health to Participate in LifeSci Partners HealthTech Symposium

    EMERYVILLE, Calif., Sept. 07, 2022 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (“Lucira Health” or “Lucira”), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, and a digital health platform that will connect patients with providers, today announced that the company will participate in the LifeSci Partners HealthTech Symposium on September 21st, 2022, at 10:30am ET. A live and archived webcast of the event can

  • Yahoo Finance Video

    Lucira CEO: COVID-19 ‘catalyzed the growth of the company’

    Lucira CEO Erik Engelson joins Yahoo Finance Live to discuss company earnings and the future of at-home COVID-19 and flu testing.

Advertisement
Advertisement